Wheeler Bio, a contract development and manufacturing organization (CDMO) for next-gen protein therapeutics, opened a state-of-the-art drug substance cGMP facility in Oklahoma City, OK. The new 35,000 square-foot cGMP facility is comprised of two single-use drug substance lines (50L and 500L scale HyPerforma DynaDrive), warehousing, cold chain, a buffer and media prep suite, two master cell banking suites, a RightSource quality control testing lab (Charles River Labs), document control, utili...